Launched with help from Cedars-Sinai, the National Institutes of Health’s All of Us Research Program, is gathering genetic, biological, environmental, health, and lifestyle data from a million volunteers over 10 years. The program will use this valuable data for thousands of studies into a wide variety of health conditions in order to develop more effective ways to prevent and treat disease.
The Mitra Microsampler is an at-home blood-draw tool that helps patients collect tiny drops of blood for precise biometric monitoring and heart health.
Medicine has never had more power than it does at this moment: power to detect, diagnose, prevent, and heal. An ever-deepening understanding of genetics and the function of cells, along with radical advances in informatics, herald a transformation in personalized health.
A study at Cedars-Sinai applies its individualized tactics to investigate how adverse pregnancy outcomes can be used to identify women at risk for cardiovascular disease.
Precision medicine can be thought of as a science of small details. By taking the microscopic view, it’s helping medicine draw a bigger, clearer picture.
Jennifer Van Eyk is a leader in proteomics, which uses molecular biology, biochemistry, and genetics to analyze the structure, functions, and interactions of proteins.
You may have heard the phrase “precision health” or “precision medicine” a lot lately. Or perhaps you’ve heard the terms “personalized medicine” and “individualized medicine.” Whatever the phrasing, all describe tailored diagnostic and treatment systems that provide customized care to every patient, every time.
At Cedars-Sinai, a new technique called extended blood matching uses genetics for blood typing and matching, making blood transfusions safer than ever before.